Internal Medicine, Infectious Disease · Tampa, FL
NPI
1760477442
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3317 W Gandy Blvd
Tampa, FL, 33611
Phone (813) 902-8600
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
348 services
Medicare patients, 2024
94
Average age 70
Drug cost, 2024
$6.5M
5,344 prescriptions
Company payments, 2025
$412
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael E Dunn was code 99213 (office e&m - established), 162 times for 86 patients. In total Michael E Dunn billed 348 services in 11 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 162 | 86 | $70.68 | $11K |
| 36415 Venipuncture Blood Collection | Office | 125 | 56 | $8.58 | $1,073 |
| 99214 Office E&M - Established | Office | 27 | 23 | $106.06 | $2,864 |
By year: 2022 $18K for 302 services; 2023 $121K for 6,023 services; 2024 $16K for 348 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 125 | 56 | $8.58 | $1,073 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael E Dunn prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 638 prescriptions and refills. In total Michael E Dunn wrote 5,344 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 638 | 638 | 75 | $2.6M |
| Atorvastatin Calcium Generic | 254 | 444 | 55 | $1,341 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 197 | 207 | 22 | $819K |
| Omeprazole Generic | 164 | 175 | 20 | $1,003 |
| Prezcobix Darunavir/Cobicistat | 162 | 162 | 17 | $404K |
| Rosuvastatin Calcium Generic | 157 | 227 | 31 | $1,254 |
| Tivicay Dolutegravir Sodium | 143 | 143 | 17 | $359K |
| Dovato Dolutegravir Sodium/Lamivudine | 134 | 142 | 16 | $417K |
| Testosterone Cypionate Generic | 122 | 122 | 16 | $2,241 |
| Alprazolam Generic | 122 | 122 | 19 | $654 |
| Losartan Potassium Generic | 117 | 154 | 21 | $685 |
| Trazodone Hcl Generic | 103 | 127 | 15 | $525 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 102 | 102 | 12 | $476K |
| Descovy Emtricitabine/Tenofov Alafenam | 101 | 101 | Under 11 | $222K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 90 | 90 | 11 | $344K |
Brand drugs: - claims; generic drugs: 3,229 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael E Dunn $412 ($412 in general payments such as food, travel and fees) from 7 companies. The largest payer was Gilead Sciences, Inc. with $231.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.